Despite the enthusiasm Prime Minister Justin Trudeau tried to bring to his announcement Tuesday, when he said that Canada had struck a deal to manufacture millions of COVID-19 vaccines at home, the agreement won’t do much to get us out of the acute phase of this pandemic.
That’s because the deal with Novavax to churn out its vaccine at Canada’s National Research Council (NRC) in Montreal is contingent on the completion of a new production centre, which won’t be finished until summer or early fall.
